Last reviewed · How we verify
Intravenous brivaracetam
Intravenous brivaracetam is a Small molecule drug developed by Muhammad Aamir Latif. It is currently in Phase 1 development.
At a glance
| Generic name | Intravenous brivaracetam |
|---|---|
| Sponsor | Muhammad Aamir Latif |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Epileptic Hippocampus in Alzheimer's Disease (PHASE1, PHASE2)
- Comparison of Intravenous Brivaracetam Versus Levetiracetam in the Management of Status Epilepticus (NA)
- A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic Seizures (PHASE3)
- A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With Epilepsy (PHASE2)
- A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization (PHASE3)
- A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting (PHASE2)
- Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint (PHASE2, PHASE3)
- A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intravenous brivaracetam CI brief — competitive landscape report
- Intravenous brivaracetam updates RSS · CI watch RSS
- Muhammad Aamir Latif portfolio CI
Frequently asked questions about Intravenous brivaracetam
What is Intravenous brivaracetam?
Intravenous brivaracetam is a Small molecule drug developed by Muhammad Aamir Latif.
Who makes Intravenous brivaracetam?
Intravenous brivaracetam is developed by Muhammad Aamir Latif (see full Muhammad Aamir Latif pipeline at /company/muhammad-aamir-latif).
What development phase is Intravenous brivaracetam in?
Intravenous brivaracetam is in Phase 1.
Related
- Manufacturer: Muhammad Aamir Latif — full pipeline
- Compare: Intravenous brivaracetam vs similar drugs
- Pricing: Intravenous brivaracetam cost, discount & access